, APAC
15 views

APAC to record fastest-growing clinical chemistry market

Currently, North America dominates the market across the globe.

Asia Pacific is projected to have the fastest-growing clinical chemistry market for 2021-2026, with the most rapid emerging markets in nations such as China, Japan, and India and their development of healthcare infrastructure, according to a report from Fortune Business Insights.

Currently, North America is holding the dominant clinical chemistry market share, with its presence of well-established healthcare infrastructure and facilities. Government-supported initiatives and reimbursement facilities will further help this region continue dominance in the coming years as well.

Globally, the increasing prevalence of acute, chronic, and infectious diseases are boosting the clinical chemistry market growth. Further, the rising demand for accurate and quick diagnostic procedures is also expected to ramp up the clinical chemistry market revenue.

Additionally, a sedentary lifestyle, unhealthy eating, and drinking habits are also anticipated to help increase the clinical chemistry market size in the coming years. Also helping is, the rise in disposable incomes of people and the adoption of advanced diagnostic procedures.

On the other hand, the lack of skilled professionals for conducting clinical chemistry tests may hamper the overall clinical chemistry market size. The high cost of clinical chemistry tests could also restrict clinical chemistry market growth in the developing markets.
 

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Get Health Care Asia Magazine in your inbox
It was recognised for its cutting-edge medical device packaging design, Dispenser Integrated System Kit (DISK).
There has been an expanding research base across India, China, and Japan.
It combines third-party assured data verification with blockchain technology.
Consultation is available for only $0.014 (INR1).
The number of hospitals operating on hip fracture that have access to a fracture liaison service has been steadily rising from 2013 to 2020.
GMT Manila’s award-winning initiative, in collaboration with Endec Inc. and Scilore LLC, is a rapidly deployable turnkey solution for RT-PCR Testing that made it more available across the Philippines. 
As The National Cardiovascular Referral Center in Indonesia, NCCHK has been acknowledged by Asia's Healthcare Industry.
Currently, North America dominates the market across the globe.
More medical devices are being bought for home use.
It has also introduced a new hotline service.
The firm was recognised for its multiple initiatives in braving the COVID-19 crisis.
It took home the Training Initiative of the Year trophy for its non-invasive therapy treatment for benign prostatic hyperplasia (BPH).
The country’s SII makes up about half of Covax supply.
It owns 39 hospitals and eight clinics across England, Wales, and Scotland.
The company plans to set up over 100 in-school clinics.